Cd. Wegner et al., THE ROLE OF 5-LIPOXYGENASE PRODUCTS IN PRECLINICAL MODELS OF ASTHMA, Journal of allergy and clinical immunology, 91(4), 1993, pp. 917-929
Background: The action of 5-lipoxygenase on arachidonic acid generates
potent inflammatory mediators that may contribute to the pathophysiol
ogy of asthma. Methods: Using the potent and selective 5-lipoxygenase
inhibitor BI-L-239, we have examined the role of 5-lipoxygenase produc
ts in three animal models of asthma. Results: In vitro BI-L-239 inhibi
ted 5-lipoxygenase product generation from human lung mast cells, alve
olar macrophages, and peripheral blood leukocytes with a concentration
that would provide 50% inhibition values of 28 to 340 nmol/L. A 36-fo
ld selectivity for immunoreactive leukotriene C4 versus immunoreactive
prostaglandin D2 inhibition was demonstrated in mast cells. In anesth
etized cynomolgus monkeys, inhaled BI-L-239 provided dose-dependent in
hibition of the inhaled Ascaris-induced immunoreactive leukotriene C4
release (maximum, 73%; bronchoalveolar lavage [BAL], 20 minutes), late
-phase bronchoconstriction (maximum, 41%; +6 to 8 hours), and neutroph
il infiltration (maximum, 63%; BAL, +8 hours). In conscious sheep, inh
aled BI-L-239 provided dose-dependent inhibition of the inhaled Ascari
s-induced late-phase bronchoconstriction (maximum, 66%; +6 to 8 hours)
and increase in airway responsiveness (maximum, 82%; carbachol, +24 h
ours). The acute bronchoconstriction was shortened, and neutrophil inf
iltration diminished (maximum, 61%; BAL, +8 hours) in this model. Fina
lly in conscious actively sensitized guinea pigs pretreated with pyril
amine and indomethacin, inhaled BI-L-239 attenuated acute bronchoconst
riction (maximum, 80%; +5 to 15 minutes), leukocyte infiltration (58%;
BAL, +3 days) and increase in airway responsiveness (100%; methacholi
ne, +3 days) induced by three alternate-day ovalbumin inhalations. Con
clusions: In conclusion, results in these three animal models indicate
that 5-lipoxygenase products may be major contributors to the broncho
constriction (especially late phase), leukocyte infiltration, and airw
ay hyperresponsiveness that characterize asthma.